New class of pentraxin therapeutics to treat rare fibrotic diseases, including: idiopathic pulmonary fibrosis (IPF), myelofibrosis, and fibrovascular....
Work for Promedior? Take ownership of your company’s profile and submit the latest details about your company to keep the investors, strategics, and service providers using our database up-to-date on the work being done at your company.
